AUDRA MCCALL: Open Payments
NPI 1306845524 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 30 payments from 22 companies in 2025. Trend: 2023 $1,950 · 2024 $1,437 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $227 |
| Janssen Pharmaceuticals, Inc | 2 | $148 |
| AstraZeneca Pharmaceuticals LP | 3 | $76 |
| Amgen Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: SPRAVATO, AUSTEDO XR, UZEDY, AIRSUPRA, JARDIANCE, REXULTI, EVENITY, ZENPEP.
Industry payments across OK — which companies pay providers there.
